Cargando…

Epigenetic silencing of MEIS2 in prostate cancer recurrence

BACKGROUND: Current diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, resulting in overdiagnosis and overtreatment of clinically insignificant tumors. Thus, to improve the management of PC, novel biomarkers are urgently needed. RESULTS: In this study, we integrated genome-wide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nørgaard, Maibritt, Haldrup, Christa, Bjerre, Marianne Trier, Høyer, Søren, Ulhøi, Benedicte, Borre, Michael, Sørensen, Karina D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805635/ https://www.ncbi.nlm.nih.gov/pubmed/31640805 http://dx.doi.org/10.1186/s13148-019-0742-x

Ejemplares similares

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
por: Bjerre, Marianne Trier, et al.
Publicado: (2020)

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
por: Nørgaard, Maibritt, et al.
Publicado: (2017)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
por: Bjerre, Marianne T., et al.
Publicado: (2019)

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
por: Schmidt, Linnéa, et al.
Publicado: (2018)

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
por: Møller, Mia, et al.
Publicado: (2017)

Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling
por: Salachan, Paul Vinu, et al.
Publicado: (2022)

RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
por: Strand, Siri H., et al.
Publicado: (2016)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)

Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by (68)Ga-PSMA PET/CT
por: Christensen, Mads T., et al.
Publicado: (2022)

Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
por: Fredsøe, Jacob, et al.
Publicado: (2020)

The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
por: Hansen, Emma Bollmann, et al.
Publicado: (2022)

Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
por: Renaud, Gabriel, et al.
Publicado: (2022)

Safety and Effects of Football in Skeletal Metastatic Prostate Cancer: a Subgroup Analysis of the FC Prostate Community Randomised Controlled Trial
por: Bjerre, Eik Dybboe, et al.
Publicado: (2021)

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
por: Storebjerg, Tine Maj, et al.
Publicado: (2018)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

Mei : per flauto solo (1962)
por: Fukushima, Kazuo
Publicado: (1966)

Structural insights reveal the specific recognition of meiRNA by the Mei2 protein
por: Shen, Siyuan, et al.
Publicado: (2022)

Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening
por: Haldrup, Jakob, et al.
Publicado: (2023)

DNAfusion: an R/Bioconductor package for increased sensitivity of detecting gene fusions in liquid biopsies
por: Maansson, Christoffer Trier, et al.
Publicado: (2023)

Beyond Climate Focus and Disciplinary Myopia. The Roles and Responsibilities of Hospitals and Healthcare Professionals
por: Ulhøi, John P., et al.
Publicado: (2009)

My mentors (Dascălii mei)
por: Bârsu, Cristian
Publicado: (2013)

Meis: New friends of Pax
por: Schulte, Dorothea
Publicado: (2014)

MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy
por: Blasi, Francesco, et al.
Publicado: (2021)

The Danish Prostate Cancer Database
por: Nguyen-Nielsen, Mary, et al.
Publicado: (2016)

Regulation of the MEI-1/MEI-2 Microtubule-Severing Katanin Complex in Early Caenorhabditis elegans Development
por: Beard, Sarah M., et al.
Publicado: (2016)

First person – Mei-Fang Lin
Publicado: (2019)

An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes
por: Bekker-Jensen, Dorte B., et al.
Publicado: (2017)

DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2016)

Microtubule severing by the katanin complex is activated by PPFR-1–dependent MEI-1 dephosphorylation
por: Gomes, José-Eduardo, et al.
Publicado: (2013)

Study of the dynamic expression of Meis1 in mice
por: Hai-Xia, Li, et al.
Publicado: (2013)

Cardiomyocyte cell cycle: Meis-ing something?
por: Mahmoud, Ahmed I, et al.
Publicado: (2014)

AQP9 Expression in Glioblastoma Multiforme Tumors Is Limited to a Small Population of Astrocytic Cells and CD15(+)/CalB(+) Leukocytes
por: Jelen, Sabina, et al.
Publicado: (2013)

Erratum: DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia
por: Ferreira, H J, et al.
Publicado: (2017)

Quality of venous thromboembolism diagnoses among prostate cancer patients in the Danish National Registry of Patients
por: Drljevic, Aska, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gap9dgsa7bh908h65dl46tf5hi